Subject "4.20.05 Health legislation and policy"
subscribeDossiers (107)
State of Health in the EU: Synthesis Report 2023
Stepping up EU actions to combat antimicrobial resistance in a One Health approach. Proposal for a Council recommendation. Accompanying document
Medical devices: annual overview of devices subject to the clinical evaluation consultation procedure (April 2021-June 2022)
Strengthening prevention through early detection: A new EU approach on cancer screening. Proposal for a Council recommendation. Stakeholder consultation - Synopsis report. Accompanying document
State of Health in the EU. Companion report 2021
Strategic agenda for medical ionising radiation applications (SAMIRA)
State of health in the EU. Companion report 2019
Evaluation of the Union legislation on blood, tissues and cells. Executive summary
Evaluation of the Union legislation on blood, tissues and cells
Stepping up EU actions to combat antimicrobial resistance in a One Health approach. Proposal for a Council recommendation
Reform of the pharmaceutical legislation and measures addressing antimicrobial resistance
Strengthening prevention through early detection: A new EU approach on cancer screening. Proposal for a Council recommendation
Framework of measures for ensuring the supply of crisis-relevant medical countermeasures in the event of a public health emergency at Union level. Proposal for a Council Regulation
EEA Agreement: amending Protocol 31 on cooperation in specific fields outside the four freedoms (EU4Health Programme). EU position
Resolution on the urgent need to revise the Medical Devices Regulation
Gradual roll-out of Eudamed, information obligation in case of interruption of supply and transitional provisions for certain in vitro diagnostic medical devices
Specific hygiene requirements for certain meat, fishery products, dairy products and eggs: amending Annexes II et III
Assignment of Unique Device Identifiers for contact lenses
Determination of end points in the manufacturing chain of certain organic fertilisers and soil improvers
Implementation report on Regulation (EC) No1924/2006 on nutrition and health claims made on foods
Supplementary protection certificate for medicinal products. Recast
Transitional provisions for certain medical devices and in vitro diagnostic medical devices
Frequency of complete re-assessments of notified bodies
Frequency of complete re-assessments of notified bodies
Revision of the Medical Devices Regulation – how to ensure the availability of medical devices
Protection of human health: food of animal origin, specific hygiene rules. Correcting the French language version of Annex III
Fishery products, eggs and certain highly refined products, and certain bivalve molluscs
A systematic EU approach to chronic kidney disease
European Medicines Agency (EMA): appointment of four members of the Management Board
Standards of quality and safety for substances of human origin intended for human application
European Health Data Space
Protection of human health - food of animal origin, specific hygiene rules: amending Annex III
Examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products
Transitional provisions for certain in vitro diagnostic medical devices and deferred application of requirements for in-house devices
End of the derogation for slaughter establishments laid down in Regulation (EU) 2017/185
European Medicines Agency
Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”)
Medical devices
Resolution on a comprehensive European Union framework on endocrine disruptors
Derogations from Article 1(3) of Regulation (EC) No 1924/2006 on nutrition and health claims made on food for the use of certain generic descriptors
Health technology assessment
Resolution on the draft Commission regulation amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties
European One Health action plan against antimicrobial resistance (AMR)
Resolution on support for the thalidomide survivors
Resolution on endocrine disruptors: state of play following the judgment of the General Court of the European Union of 16 December 2015
Resolution on the draft Commission regulation amending Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods other than those referring to the reduction of disease risk and to children’s development and health
Criteria for identifying endocrine-disrupting chemicals
Protection of vulnerable adults
Medicinal products for human and veterinary use
Permitted health claims made on foods
Resolution on defective silicone gel breast implants made by French company PIP
Special report 14/2012 (2011 discharge): Implementation of EU hygiene legislation in slaughterhouses of countries that joined the EU since 2004
Asbestos related occupational health threats and prospects for abolishing all existing asbestos
In vitro diagnostic medical devices
Medical devices
Pharmacovigilance: transparency and efficiency of the system. Directive
Pharmacovigilance: transparency and efficiency of the system. Regulation
Resolution on European Union position and commitment in advance to the UN high-level meeting on the prevention and control of non-communicable diseases
Authorisation and refusal of authorisation of certain health claims made on foods and referring to children's development and health
Voluntary and unpaid donation of tissues and cells
Third programme for the Union's action in the field of health (2014-2020)
Basic safety standards for protection against the dangers arising from exposure to ionising radiation
Reducing health inequalities in the EU
New biocides revision proposal
Action plan on organ donation and transplantation (2009-2015): strengthened cooperation between Member States
Action against cancer: European partnership
Animal and public health: third countries authorised to import certain animals and fresh meat, and the veterinary certification requirements
Animal health requirements: non-commercial movement of pet animals
Resolution on combating cancer in the enlarged EU
Together for health: a strategic approach for the EU 2008-2013
Medicinal products for human use: pharmacovigilance of products
Standards of quality and safety of human organs intended for transplantation
Patients' rights in cross-border healthcare
Health rules: animal by-products and derived products not intended for human consumption
Medicinal products for human and veterinary use: marketing authorisations
Cosmetic products. Recast. "Cosmetics Regulation"
Declaration on the need for a comprehensive strategy to control cancer
Green Paper on the role of civil society in drugs policy in the EU
Organ donation and transplantation: policy actions at EU level
Green Paper 'Towards a Europe free from tobacco smoke: policy options at EU level'
Animal health requirements applicable to the non-commercial movements of pet animals: extension of the transitional period
Foodstuffs: nutrition and health claims used in labelling
Nutrition and health claims made on foods: Commission implementing powers
Dangerous substances and preparations: cancerogens, mutagens and toxic, c/m/r category 1 or 2 (29th amend. Directive 76/769/EEC)
Environment and health : polycyclic aromatic hydrocarbons in extender oils and tyres (27th amend. Directive 76/769/EEC)
Products of animal origin intended for human consumption: animal health rules (amend. Directives 90/426/EEC and 92/65/EEC; repeal. Directive 72/462/EEC)
Nutrition and health claims made on foods
Cancer screening
Human tissues and cells: quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution
Dangerous substances: carcinogens, mutagens, toxic to reproduction c/m/r (25th amend. Directive 76/769/EEC)
Public health: control of salmonella and food-born zoonotic agents
Public health: monitoring of zoonoses and zoonotic agents (amend. Decision 90/424/EEC, repeal. Directive 92/117/EEC)
Dangerous substances: carcinogens, mutagens or toxic to reproduction, c/m/r (23rd amend. Directive 76/769/EEC)
Health policy: animal by-products not intended for human consumption, animal proteins in animal feed
Health requirements for animal by-products
Animal health requirements: non commercial movement of pet animals
Products of animal origin, human consumption: health rules (amend. Directives 89/662/EEC, 91/67/EEC). Food hygiene package
Products of animal origin intended for human consumption: animal-health rules
Products of animal origin intended for human consumption: organisation of official controls
Protection of human health: food of animal origin, specific hygiene rules
Dangerous substances: cancerogens, mutagens and toxic, c/m/r category 1 or 2 (21st amend. Directive 76/769/EEC)
Health problems: requirements for trade in and imports of products non covered by direct. 89/662/EEC and 90/425/EEC
Animal health conditions: imports from third countries of fresh poultry meat (amend. direct. 91/494/EEC)
Certification of animals and animal products
Fresh meat: health conditions for the production and marketing
Inspection of food: monitoring of substances and residues in live animals and meat
Biocidal products for non-agricultural uses: common rules for national authorisations
Subscribe